Compare Stocks → Your $200 account credit is about to expire (From MarketBeat) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NASDAQ:MOTSNASDAQ:QNRXNYSE:RMEDNASDAQ:SINT Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMOTSMotus GI$0.44+4.8%$0.69$0.40▼$23.40$2.21M1.341.70 million shs79,867 shsQNRXQuoin Pharmaceuticals$0.95+9.2%$2.42$0.80▼$12.00$940K1.88619,057 shs160,391 shsRMEDRa Medical Systems$0.73$0.52▼$11.14$3.19M-0.03197,480 shs77,500 shsSINTSintx Technologies$0.05$0.16$0.04▼$2.39$263K1.523.82 million shs8.23 million shsThe 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMOTSMotus GI-3.64%-19.98%-42.22%-71.30%-96.92%QNRXQuoin Pharmaceuticals+4.19%-3.33%-67.66%-83.11%-84.85%RMEDRa Medical Systems0.00%0.00%0.00%0.00%-61.92%SINTSintx Technologies+2.43%-64.24%-63.11%-87.16%-97.78%Major Elon Musk Crypto Leak Revealed (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMOTSMotus GI2.5727 of 5 stars3.55.00.00.02.70.00.6QNRXQuoin Pharmaceuticals1.9498 of 5 stars3.53.00.00.03.00.00.6RMEDRa Medical SystemsN/AN/AN/AN/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMOTSMotus GI3.00Buy$28.886,477.45% UpsideQNRXQuoin Pharmaceuticals3.00Buy$4.00321.05% UpsideRMEDRa Medical SystemsN/AN/AN/AN/ASINTSintx Technologies2.00HoldN/AN/ACurrent Analyst RatingsLatest RMED, MOTS, QNRX, and SINT Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/15/2024QNRXQuoin PharmaceuticalsMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$15.00 ➝ $4.002/5/2024SINTSintx TechnologiesMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold(Data available from 3/28/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMOTSMotus GI$320K6.90N/AN/A$1.74 per share0.25QNRXQuoin PharmaceuticalsN/AN/AN/AN/A$5.74 per shareN/ARMEDRa Medical Systems$10K0.00N/AN/A$4.29 per share0.00SINTSintx Technologies$1.56M0.17N/AN/A$10.52 per share0.00Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMOTSMotus GI-$12.87M-$28.55N/A∞N/A-4,033.54%-3,413.36%-110.70%5/8/2024 (Estimated)QNRXQuoin Pharmaceuticals-$8.69M-$10.24N/A∞N/AN/A-105.09%-55.69%5/13/2024 (Estimated)RMEDRa Medical Systems-$26.86M-$92.36N/AN/AN/AN/A-496.57%-344.49%N/ASINTSintx Technologies-$12.04MN/A0.00∞N/A-397.27%-85.77%-54.20%5/20/2024 (Estimated)DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMOTSMotus GIN/AN/AN/AN/AN/AQNRXQuoin PharmaceuticalsN/AN/AN/AN/AN/ARMEDRa Medical SystemsN/AN/AN/AN/AN/ASINTSintx TechnologiesN/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMOTSMotus GI0.461.761.69QNRXQuoin PharmaceuticalsN/A3.153.15RMEDRa Medical SystemsN/A2.862.85SINTSintx TechnologiesN/A2.091.87OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMOTSMotus GI20.06%QNRXQuoin Pharmaceuticals8.63%RMEDRa Medical Systems11.00%SINTSintx Technologies18.38%Insider OwnershipCompanyInsider OwnershipMOTSMotus GI1.57%QNRXQuoin Pharmaceuticals3.30%RMEDRa Medical Systems18.62%SINTSintx Technologies1.00%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableMOTSMotus GI435.03 million4.95 millionNot OptionableQNRXQuoin Pharmaceuticals4990,000954,000Not OptionableRMEDRa Medical Systems145.37 million4.37 millionNot OptionableSINTSintx Technologies415.32 million5.27 millionNot OptionableRMED, MOTS, QNRX, and SINT HeadlinesSourceHeadlineSINT Stock Earnings: SINTX Technologies Beats EPS, Beats Revenue for Q4 2023investorplace.com - March 28 at 7:02 AMSintx Technologies Prices Public Offering Of $1.3 Mln Of Sharesmarkets.businessinsider.com - March 25 at 1:22 PMWhy SINTX Technologies Stock Is Down 50%msn.com - March 25 at 1:22 PMWhy Is Sintx Technologies (SINT) Stock Down 31% Today?investorplace.com - March 25 at 9:05 AMSINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stockglobenewswire.com - March 25 at 9:00 AMUS Stocks Edge Lower; FedEx Posts Upbeat Earningsmsn.com - March 23 at 3:15 AMWhy SINTX Technologies Is Trading Higher Todayaol.com - March 22 at 10:14 PMGold Moves Lower; Lululemon Shares Plummetmsn.com - March 22 at 5:14 PMDow Dips 200 Points; Nike Shares Fall After Q3 Resultsmarkets.businessinsider.com - March 22 at 5:14 PMSINTX Technologies Announces Intend To Offer And Sell Shares Of Common Stock; Stock Down 34%markets.businessinsider.com - March 22 at 5:14 PMWhy SINTX Technologies Stock Is Nosedivingmsn.com - March 22 at 5:14 PMSINTX Technologies Announces Proposed Public Offering of Common Stockglobenewswire.com - March 22 at 8:30 AMSintx Technologies (SINT) Price Target Increased by 42.86% to 10.20msn.com - February 24 at 2:14 PMTop 4 Health Care Stocks That Are Preparing To Pump This Month - ProSomnus (NASDAQ:OSA), GRI Bio (NASDAQ:GRI)benzinga.com - February 23 at 7:50 AMSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETfinance.yahoo.com - February 21 at 3:58 PMSINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKETglobenewswire.com - February 21 at 9:00 AMSINTX Technologies: Other Eventscbonds.com - February 16 at 10:37 AMSINTX Technologies subsidiary enters R&D agreement with the U.S. Army DEVCOM ARL for ceramic additive manufacturingtctmagazine.com - February 7 at 10:57 AMSintx Technologies just downgraded at Maxim, here's whyrealmoney.thestreet.com - February 5 at 5:59 PMSINTX Technologies: Entry Into A Material Definitive Agreement, Other Events, Financial Statements And Exhibitscbonds.com - February 5 at 12:58 PMSintx Technologies Announces New Offering Detailsmsn.com - February 3 at 8:14 AMSINTX Technologies Announces Closing of $4.0 Million Public Offeringfinance.yahoo.com - February 2 at 3:27 PMSintx Technologies Partners with U.S. Army for 3D Printing Advancementsmsn.com - February 1 at 7:39 AMSintx Tech Announces Pricing Public Offering; Stock Downmarkets.businessinsider.com - February 1 at 2:08 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesHow to Invest in Artificial Intelligence in These Simple WaysMarch 7, 2024 1:08 PMView How to Invest in Artificial Intelligence in These Simple Ways5 Under-the-Radar Artificial Intelligence (AI) Stocks March 4, 2024 9:30 AMView 5 Under-the-Radar Artificial Intelligence (AI) Stocks McCormick & Company Stock Isn’t Cheap, But It Is UndervaluedMarch 26, 2024 10:28 AMView McCormick & Company Stock Isn’t Cheap, But It Is UndervaluedGeneral Mills Stock Price Reversal Gains Momentum on Good NewsMarch 20, 2024 9:30 AMView General Mills Stock Price Reversal Gains Momentum on Good NewsEnergy Sector Nears Multi-Year Resistance: Breakout Ahead?March 21, 2024 8:45 AMView Energy Sector Nears Multi-Year Resistance: Breakout Ahead?All Headlines Company DescriptionsMotus GINASDAQ:MOTSMotus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. Motus GI Holdings, Inc. was founded in 2008 and is based in Fort Lauderdale, Florida.Quoin PharmaceuticalsNASDAQ:QNRXQuoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases. Its lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). The company is also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat NS; and QRX008 for the treatment of scleroderma. It has a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; a Master Service Agreement with Therapeutics Inc.; and a research agreement with Queensland University of Technology. The company was founded in 2018 and is based in Ashburn, Virginia.Ra Medical SystemsNYSE:RMEDRa Medical Systems, Inc develops and delivers electrophysiology products to provide patients, hospitals, and physicians with technologies and solutions to improve the lives of patients with cardiac arrhythmias in the United States. The company's lead product is View into Ventricular Onset System, a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. It also provides LockeT, a suture retention device; and Amigo Remote Catheter System, a robotic arm that serves as a catheter control device. Ra Medical Systems, Inc is based in Fort Mill, South Carolina.Sintx TechnologiesNASDAQ:SINTSintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.